Ligand profile
JAH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02423 — tRNA (guanine-N(1)-)-methyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
JAH- PDB
6qov- UniProt (similar protein)
B1MDI3- Target protein
- KP13_02423
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.9
- −1 ≤ LogP ≤ 5 2.21
- MW ≤ 500 Da 184.2
- LogP ≤ 5 2.21
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 38.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)c2ccc(cn2)CNc1ccc(cc1)c2ccc(cn2)CN
InChI=1S/C12H12N2/c13-8-10-6-7-12(14-9-10)11-4-2-1-3-5-11/h1-7,9H,8,13H2InChI=1S/C12H12N2/c13-8-10-6-7-12(14-9-10)11-4-2-1-3-5-11/h1-7,9H,8,13H2
YXWLMYSYKQXBQE-UHFFFAOYSA-NYXWLMYSYKQXBQE-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01746
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand JAH →
- PDB RCSB structure 6qov →
- UniProt UniProt B1MDI3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “JAH”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02423.
PDB 88
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 38
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).